Increasing clinical trial enrollment

The gift of hope


Improve access to appropriate interventions for each person’s healthcare journey, including clinical trial possibilities by location and other patient-specific factors.

Increasing clinical trial enrollment

The gift of hope


Improve access to appropriate interventions for each person’s healthcare journey, including clinical trial possibilities by location and other patient-specific factors.

Clinical trials are vital to medical advances and better patient care

Only with adequate participation can these trials return trustworthy data and move personalized healthcare forward. But structural and clinical barriers make trial participation unachievable for more than three out of four cancer patients.1

One significant obstacle is physicians’ lack of resources to identify trials for their patients and advocate for enrollment. Doctors may also worry that a trial may interfere with the physician-patient relationship or the patient’s commitment to the referring institution.

Patient enrollment is one of the biggest causes of drug development delays2

Low enrollment of cancer patients in clinical trials is well documented. The causes are many, including:

  • Limited human resources and time for cancer care teams to research clinical trials
  • Difficulty for clinicians to keep up with available trials
  • Strict inclusion/exclusion criteria
  • The lack of patient insurance coverage for clinical trials

But technology and integrated clinical decision support can simplify the identification of trials for patients based on personal preferences (e.g., location, trial duration/time commitment, costs and/or reimbursements, etc.), tumor information, trial eligibility and ineligibility criteria, and more.

Biggest clinical trial patient challenges:3

NAVIFY® icon: patient

66%

Understanding of the process

56%

Awareness of options

37%

Historical stigma

Biggest clinical trial program challenges:3

NAVIFY® icon: clinician

58%

Infrastructure

55%

Staff resources and training

46%

Physician engagement

Clinical trial enrollment benefits

Increased clinical trial enrollment benefits all of oncology, including precision medicine and personalized healthcare.

NAVIFY® icon: checkmark

Matching the right patients to an open trial:

  • Improves trial insight generation
  • Reduces clinical trial costs
  • Aids in patient retention
  • Helps develop patient profiles for future trials
  • Potentially speeds new drug approval/commercial availability
  • Informs ongoing pharmaceutical research and development

Explore
more

Partial image of the NAVIFY Clinical Trial Match information sheet

Match the right patient to the right trial in just seconds

Read more

An image of patient data from NGS

Find clinical trial opportunities based on genomic alterations

Read more

  1. Unger J. M., et al. (2019) ‘Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation’, Journal of the National Cancer Institute, 111(3), p245-255.
  2. Crist C. (2018) ‘Public seems to know value of clinical trials, but not how they work’, Reuters Health News, 11 October.
  3. Oncology Roundtable. (2019) ‘Highlights from the 2018 Trending Now in Cancer Care Survey’, Association of Community Cancer Centers.

* Powered by MolecularMatch, Inc.